A novel mouse model of subcortical infarcts with dementia

Journal of Neuroscience

Volumn 35, Issue 9, 2015, Pages 3915-3928

  Hattori, Yorito ^a   Enmi, Jun Ichiro ^b   Kitamura, Akihiro ^c   Yamamoto, Yumi ^a   Saito, Satoshi ^a,c   Takahashi, Yukako ^b,c   Iguchi, Satoshi ^b   Tsuji, Masahiro ^a   Yamahara, Kenichi ^a   Nagatsuka, Kazuyuki ^b   Iida, Hidehiro ^b   Ihara, Masafumi ^a,b  

^a Department of Regenerative Medicine ^*  (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral infarction; Model; Mouse; Stroke; Vascular dementia; White matter

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; BLOOD FLOWMETRY; BLOOD PRESSURE; BLOOD VESSEL OCCLUSION; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DEMENTIA; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; IMPLANTATION; MALE; MORTALITY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULSE RATE; SPIN LABELING; SURVIVAL RATE; WHITE MATTER; WORKING MEMORY; ANIMAL; BODY EQUILIBRIUM; BRAIN CIRCULATION; C57BL MOUSE; HEART RATE; LACUNAR STROKE; MAZE TEST; MULTIINFARCT DEMENTIA; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CONSTRICTION, PATHOLOGIC; DEMENTIA; DEMENTIA, VASCULAR; HEART RATE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; POSTURAL BALANCE; STROKE, LACUNAR;

EID: 84924785376     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3970-14.2015     Document Type: Article

References (45)

1. Albers GW, Goldstein LB, Hall D, Lesko LM (2001) Aptiganel hydrochlo-ride in acute ischemic stroke: a randomized controlled trial. JAMA 286: 2673-2682.
2. Ayata C, Dunn AK, Gursoy-Ozdemir Y, Huang Z, Boas DA, Moskowitz MA (2004) Laser speckle flowmetry for the study of cerebrovascular physiology in normal and ischemic mouse cortex. J Cereb Blood Flow Metab 24:744-755.
3. Bink DI, Ritz K, Aronica E, van der Weerd L, Daemen MJ (2013) Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J Cereb Blood Flow Metab 33:1666-1684.
4. Coltman R, Spain A, Tsenkina Y, Fowler JH, Smith J, Scullion G, Allerhand M, Scott F, Kalaria RN, Ihara M, Daumas S, Deary IJ, Wood E, McCulloch J, Horsburgh K (2011) Selective white matter pathology induces a specific impairment in spatial working memory. Neurobiol Aging 32: 2324.e7-2324.e12.
5. Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, Norris J (2000) Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 31:347-354.
6. Dewar D, Yam P, McCulloch J (1999) Drug development for stroke: impor- tance of protecting cerebral white matter. Eur J Pharmacol 375:41-50.
7. Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S (2011) Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats. J Pharmacol Exp Ther 339:358-366.
8. Dorr A, Sled JG, Kabani N (2007) Three-dimensional cerebral vasculature of the CBA mouse brain: a magnetic resonance imaging and micro computed tomography study. Neuroimage 35:1409-1423.
9. Durukan A, Tatlisumak T (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87:179-197.
10. Fisher CM (1968) The arterial lesions underlying lacunes. Acta Neuro-pathol 12:1-15.
11. Gilmour G, Iversen SD, O’Neill MF, Bannerman DM (2004) The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behav Brain Res 150:171-183.
12. Gladstone DJ, Black SE, Hakim AM; for the Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery (2002) Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33:2123-2136.
13. Hainsworth AH, Markus HS (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 28:1877-1891.
14. Hattori Y, Kitamura A, Nagatsuka K, Ihara M (2014a) A novel mouse model of ischemic carotid artery disease. PLoS One 9:e100257.
15. Hattori Y, Kitamura A, Tsuji M, Nagatsuka K, Ihara M (2014b) Motor and cognitive impairment in a mouse model of ischemic carotid artery disease. Neurosci Lett 581:1-6.
16. He Z, Yamawaki T, Yang S, Day AL, Simpkins JW, Naritomi H (1999) Experimental model of small deep infarcts involving the hypothalamus in rats: changes in body temperature and postural reflex. Stroke 30:2743-2751; discussion 2751.
17. He Z, Yang SH, Naritomi H, Yamawaki T, Liu Q, King MA, Day AL, Simpkins JW (2000) Definition of the anterior choroidal artery territory in rats using intraluminal occluding technique. J Neurol Sci 182:16-28.
18. Horn J, Limburg M (2001) Calcium antagonists for ischemic stroke: a systematic review. Stroke 32:570-576.
19. Hughes PM, Anthony DC, Ruddin M, Botham MS, Rankine EL, Sablone M, Baumann D, Mir AK, Perry VH (2003) Focal lesions in the rat central nervous system induced by endothelin-1. J Neuropathol Exp Neurol 62: 1276-1286.
20. Ihara M, Kalaria RN (2014) Understanding and preventing the development of post-stroke dementia. Expert Rev Neurother 14:1067-1077.
21. Ihara M, Tomimoto H (2011) Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res 2011:978761.
22. Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113:349-388.
23. Jiwa NS, Garrard P, Hainsworth AH (2010) Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J Neurochem 115:814-828.
24. Kaste M (2005) Use of animal models has not contributed to development of acute stroke therapies: pro. Stroke 36:2323-2324.
25. Kim SG (1995) Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 34:293-301.
26. Kim SG, Tsekos NV (1997) Perfusion imaging by a flow-sensitive alternating inversion recovery (FAIR) technique: application to functional brain imaging. Magn Reson Med 37:425-435.
27. Kitagawa K (2012) Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress. J Neurosci Res 90:1043-1054.
28. Kitamura A, Fujita Y, Oishi N, Kalaria RN, Washida K, Maki T, Okamoto Y, Hase Y, Yamada M, Takahashi J, Ito H, Tomimoto H, Fukuyama H, Takahashi R, Ihara M (2012) Selective white matter abnormalities in a novel rat model of vascular dementia. Neurobiol Aging 33:1012.e25-1012.e35.
29. Masaki T, Yanagisawa M (1992) Endothelins. Essays Biochem 27:79-89.
30. Naidoo V, Naidoo S, Mahabeer R, Raidoo DM (2004) Cellular distribution of the endothelin system in the human brain. J Chem Neuroanat 27:87-98.
31. Nakagomi S, Kiryu-Seo S, Kiyama H (2000) Endothelin-converting enzymes and endothelin receptor B messenger RNAs are expressed in different neural cell species and these messenger RNAs are coordinately induced in neurons and astrocytes respectively following nerve injury. Neuroscience 101:441-449.
32. O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59:467-477.
33. Pantoni L, Garcia JH (1995) The significance of cerebral white matter abnormalities 100 years after Binswanger’s report. A review. Stroke 26: 1293-1301.
34. Richard Green A, Odergren T, Ashwood T (2003) Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 24:402-408.
35. Roma´n GC, Erkinjuntti T,WallinA,PantoniL,ChuiHC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1:426-436.
36. Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ, Rundek T, Snipes RG, Thompson JL (2001) Glycine antagonist in neu-roprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA 285:1719-1728.
37. Shibata M, Ohtani R, Ihara M, Tomimoto H (2004) White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoper-fusion. Stroke 35:2598-2603.
38. Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, Ohtani R, Ihara M, Takahashi R, Tomimoto H (2007) Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38:2826-2832.
39. Tanaka Y, Imai H, Konno K, Miyagishima T, Kubota C, Puentes S, Aoki T, Hata H, Takata K, Yoshimoto Y, Saito N (2008) Experimental model of lacunar infarction in the gyrencephalic brain of the miniature pig: neurological assessment and histological, immunohistochemical, and physiological evaluation of dynamic corticospinal tract deformation. Stroke 39: 205-212.
40. Udaka F, Sawada H, Kameyama M (2002) White matter lesions and dementia: MRI-pathological correlation. Ann N Y Acad Sci 977:411-415.
41. Uesugi M, Kasuya Y, Hama H, Yamamoto M, Hayashi K, Masaki T, Goto K (1996) Endogenous endothelin-1 initiates astrocytic growth after spinal cord injury. Brain Res 728:255-259.
42. Uesugi M, Kasuya Y, Hayashi K, Goto K (1998) SB209670, a potent endo-thelin receptor antagonist, prevents or delays axonal degeneration after spinal cord injury. Brain Res 786:235-239.
43. Wakita H, Tomimoto H, Akiguchi I, Kimura J (1994) Glial activation and white matter changes in the rat brain induced by chronic cerebral hypo-perfusion: an immunohistochemical study. Acta Neuropathol 87:484-492.
44. Wakita H, Tomimoto H, Akiguchi I, Kimura J (1995) Protective effect of cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion. Stroke 26:1415-1422.
45. Washida K, Ihara M, Nishio K, Fujita Y, Maki T, Yamada M, Takahashi J, Wu X, Kihara T, Ito H, Tomimoto H, Takahashi R (2010) Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to per-oxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion. Stroke 41:1798-1806.